Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Published:2018-10-15 Issue:4 Volume:50 Page:1226-1237
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Sabatier Renaud,Diéras Véronique,Pivot Xavier,Brain Etienne,Roché Henri,Extra Jean-Marc,Monneur Audrey,Provansal Magali,Tarpin Carole,Bertucci François,Viens Patrice,Zemmour Christophe,Gonçalves Anthony

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2017-446.pdf

Reference29 articles.

1. Global cancer statistics, 2012

2. Correction to: 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

3. Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

4. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

5. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging treatment approaches for triple-negative breast cancer;Medical Oncology;2023-12-01

2. Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach;Cancer Chemotherapy and Pharmacology;2022-01-08

3. Natural products in chemotherapy of cancers;New Strategies Targeting Cancer Metabolism;2022

4. Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending story;Expert Opinion on Drug Safety;2021-10-13

5. Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer;Journal of Clinical Medicine;2021-03-18